Two Leading Cancer Organizations, ASCO and AACR, Take a Stand on E-Cigarettes

A Food and Drug Administration proposal to regulate e-cigarettes does not go far enough, the American Society of Clinical Oncology and the American Association for Cancer Research say.

The two societies offered their general support for the agency’s proposed rule that would broaden its regulatory oversight over tobacco products in general, but offered suggestions to take the proposal even further.

In the area of e-cigarettes, the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR) called for the agency to regulate both electronic nicotine delivery systems (ENDS) as well as the component parts such as the liquids sold separately as refills for e-cigarettes. Additionally, the FDA "should develop a product standard that would require all e-liquid refill bottles to be childproof, including childproof caps for eye-dropper refill bottles," the societies said in comments they submitted together to the FDA on the proposed changes. "Future research may point to the need for additional product changes for ENDS, including standards regulating design, constituents, nicotine levels, or other chemicals including ENDS vapor, and we encourage [the] FDA to require such changes as appropriate to protect the public health."

Read the original report here: http://bit.ly/1nZDeAR

Source:The Oncology Practice